| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Pain | 13 | 7 | |
| Inflammation | 4 | 2 | |
| Muscle pain | 3 | 2 | |
| Migraine | 2 | 3 | |
| Multiple sclerosis | 2 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 17 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Pain | 13 | 7 | |
| Inflammation | 4 | 2 | |
| Muscle pain | 3 | 2 | |
| Migraine | 2 | 3 | |
| Multiple sclerosis | 2 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 17 |